Fiji vs Netherlands: HIV-positive TB patients on ART (antiretroviral therapy)
Fiji
66.0%
in 2024
Netherlands
61.0%
in 2022
Fiji rank
132nd
Netherlands rank
135th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Fiji
- Netherlands
How they compare
Fiji currently reports 66.0% against 61.0% in Netherlands, a difference of 5.0%.
That makes Fiji's figure about 1.1 times Netherlands's.
The two have swapped places 2 times across 7 shared years of data; in 2016 it was Fiji ahead.
Fiji ranks 132nd and Netherlands ranks 135th of 144 countries.
Fiji has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Fiji | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 95.8% | 63.2% | 32.5% | Fiji |
| 2020s | 88.7% | 72.3% | 16.3% | Fiji |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Fiji or Netherlands?
- Fiji, at 66.0% against 61.0% in Netherlands as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Fiji and Netherlands?
- 5.0%, with Fiji ahead.
- How many years of comparable data are there for Fiji and Netherlands?
- 7 years are reported by both, from 2016 to 2022.
- How do Fiji and Netherlands rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Fiji ranks 132nd and Netherlands ranks 135th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.